HCV Eradication with Direct-Acting Antivirals Does Not Impact HCC Progression on the Waiting List or HCC Recurrence after Liver Transplantation

BACKGROUND: The introduction of direct-acting antivirals (DAA) for HCV has led to high rates of HCV eradication. Treatment of patients awaiting liver transplantation (LT) has been controversial. Recent data suggests that DAA treatment may accelerate recurrent HCC. The impact of DAA on delisting for...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Can J Gastroenterol Hepatol
Main Authors: Emamaullee, Juliet A., Bral, Mariusz, Meeberg, Glenda, Montano-Loza, Aldo J., Bain, Vincent G., Burak, Kelly Warren, Bigam, David, Shapiro, A. M. James, Kneteman, Norman
Formato: Artigo
Idioma:Inglês
Publicado em: Hindawi 2019
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6354133/
https://ncbi.nlm.nih.gov/pubmed/30775356
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2019/2509059
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados